Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Teledyne Hanson Releases Phoenix Dry Heat Diffusion Cell Testing

Teledyne Hanson Research
Posted on: 02 Apr 18
Teledyne Hanson Releases Phoenix Dry Heat Diffusion Cell Testing Teledyne Hanson's new family of solutions for transdermal release-rate measurement refines the art of diffusion cell testing.

PR Newswire

LOS ANGELES, April 2, 2018

LOS ANGELES, April 2, 2018 /PRNewswire/ -- Teledyne Hanson Research today announced the release of the Phoenix™ family of dry-heat dissolution testing instruments. The Phoenix product line-up includes an advanced dry-heat diffusion cell, a compact six-cell manual sampling system, and a robotic platform capable of unattended testing of up to 24 diffusion cells at once.

Diffusion-cell testing of topical and transdermal products has been known to be cumbersome, time-consuming and subject to inconsistencies due to variances in operational procedures. Dissolution testing by comparison produces significantly more precise results. With the new Phoenix family of diffusion testing products, this gap has been closed. The new Phoenix dry-heat diffusion cell is more precise, easier to use, and less prone to operator error. The Phoenix DB-6, a six-cell manual sampling system, is faster to set up, easier to operate, and is controlled by an advanced single-board computer with a powerful processor, color-touch screen display, large data-storage capacity, and built-in SQL database. The Phoenix RDS automated platform employs the same six-cell blocks as the DB-6, providing modularity and ease of upgrade from manual to automated lab procedures. The system operates unattended on an XYX platform controlled by a Windows workstation capable of running two RDS platforms containing up to 24 diffusion cells at once. Programming is fast and easy, and the gains in cost, consistency, lab capacity and throughput are significant.

"Hanson has been an innovator in diffusion cell testing since first introducing the definitive Model A contained in USP <1724>. Our decades of experience in diffusion cell testing have now culminated in a new level of precision and efficiency in the Phoenix line of diffusion testing solutions," explained Keith Hamman, President and General Manager of Teledyne Hanson Research. For further details, including a video outlining the key features of the new product family, please visit

Teledyne Hanson Research, a division of Teledyne Instruments, Inc., specializes in the design and manufacture of precision analytical instruments used in pharmaceutical and nutraceutical manufacturing, research, and quality control. Hanson Research was founded in 1951 by Bill Hanson, the innovator of the modern six-vessel dissolution tester and the Model A diffusion cell. Hanson's testers, autosamplers, and related accessories are used by scientists in more than 75 countries supported by a global network of service engineers. Hanson Research was acquired by Teledyne Instruments in December 2016. For further information, please visit

John Simmons
Teledyne Hanson Research

Related Images

Phoenix Automated Diffusion Testing
Robotic sampling with an angled probe mimics precision manual sampling procedures

Phoenix Dry Heat Diffusion Cell
The Phoenix dry heat heat cell produces higher precision diffusion test results

Phoenix DB-6 Manual Sampling System
The Phoenix DB-6 provides manual sampling and ease of use in a compact footprint.

Phoenix RDS Automated Sampling System
The Phoenix RDS allows unattended operation of up to 24 diffusion cells at once.

Related Links

Phoenix Dry Heat Systems

Diffusion Testing

Related Video

View original content with multimedia:

SOURCE Teledyne Hanson Research

PR Newswire

Last updated on: 02/04/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.